BCAT2 and cancer: In conclusion, during the growth and proliferation of pancreatic ductal cancer cells, BCAT2 was involved in different pro-proliferative pathways, and inhibition of malignant tumor proliferation by gene knockout of BCAT2 may confer this strategy for targeted therapy of pancreatic ductal cancer.